As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Articles|May 1, 2002
- Volume 0 0
Free Online Diabetes Test
Advertisement
?Could you have diabetes and not know it?? That?s the teaser question posed in the ?Diabetes Risk Test? on the World Wide Web. Created by the American Diabetes Association, this 7-question quiz is designed to help individuals get a quick handle on their chances of having diabetes. As the opening information notes, diabetes is more common in African Americans, Latinos, Native Americans, Asian Americans, and Pacific Islanders. ?If you are a member of one of these ethnic groups, you need to pay special attention to this test.?
The test is easy to take. To do so, go to
Articles in this issue
over 24 years ago
HOT OTC Introductions in 2001over 24 years ago
Making the "White" Choice: OTC Tooth-Whitening Productsover 24 years ago
Norelgestromin/ Ethinyl Estradiol (Ortho Evra)over 24 years ago
Lawyers Have Latitude in Closing Argumentsover 24 years ago
Incomplete Directions Can Lead to Dispensing Errorsover 24 years ago
Pharmacodynamic Drug Interactions with Ziprasidoneover 24 years ago
An Update on Hepatitis Cover 24 years ago
Medication Advice for Travelersover 24 years ago
Allergic Rhinitis: A Focus on Nonprescription Therapyover 24 years ago
Animal Protein May Protect Bone Mineral DensityAdvertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
4
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
5